AOXG — Aoxing Pharmaceutical Balance Sheet
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.31m
- $19.93m
- $32.33m
Annual balance sheet for Aoxing Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2012 June 30th | 2013 June 30th | C2014 June 30th | C2015 June 30th | C2016 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-Q | 10-Q |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.68 | 4.01 | 2.33 | 5.37 | 6.91 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.8 | 2.84 | 3.89 | 5.85 | 11.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 9.52 | 11.9 | 10.9 | 21.1 | 26.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 27 | 26.9 | 26.4 | 28.7 | 25.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 45.1 | 39.7 | 38.1 | 53 | 56.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 18.6 | 21.7 | 34.2 | 41.2 | 37.8 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 23.2 | 34.1 | 40.6 | 41.8 | 37.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 21.9 | 5.67 | -2.51 | 11.2 | 19.1 |
| Total Liabilities & Shareholders' Equity | 45.1 | 39.7 | 38.1 | 53 | 56.2 |
| Total Common Shares Outstanding |